$LRMR
Larimar Therapeutics, Inc.

2017 Q3 Form 10-Q Financial Statement

#000119312517252840 Filed on August 09, 2017

View on sec.gov

Income Statement

Concept 2017 Q3 2017 Q2 2016 Q2
Revenue $0.00 $0.00 $0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $3.120M $3.010M $4.900M
YoY Change -35.4% -38.57% -3.54%
% of Gross Profit
Research & Development $9.723M $10.53M $10.16M
YoY Change -2.78% 3.59% -18.86%
% of Gross Profit
Depreciation & Amortization $50.00K $50.00K $50.00K
YoY Change 0.0% 0.0%
% of Gross Profit
Operating Expenses $12.84M $13.54M $15.06M
YoY Change -13.42% -10.13% -14.47%
Operating Profit -$12.84M -$13.54M -$15.06M
YoY Change -13.42% -10.13% -14.47%
Interest Expense $31.00K $53.00K $140.0K
YoY Change -76.52% -62.14% -34.27%
% of Operating Profit
Other Income/Expense, Net $255.0K $189.0K $34.00K
YoY Change 63.46% 455.88% -123.29%
Pretax Income -$12.59M -$13.35M -$15.03M
YoY Change -14.24% -11.18% -15.37%
Income Tax
% Of Pretax Income
Net Earnings -$12.59M -$13.35M -$15.03M
YoY Change -14.24% -11.19% -15.36%
Net Earnings / Revenue
Basic Earnings Per Share
Diluted Earnings Per Share -$5.498M -$5.855M -$6.621M
COMMON SHARES
Basic Shares Outstanding 27.48M shares 27.37M shares 27.27M shares
Diluted Shares Outstanding

Balance Sheet

Concept 2017 Q3 2017 Q2 2016 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $93.18M $106.0M $150.5M
YoY Change -32.8% -29.56% -31.64%
Cash & Equivalents $19.19M $31.73M $20.03M
Short-Term Investments $73.99M $74.27M $130.4M
Other Short-Term Assets $2.000M $1.600M $1.300M
YoY Change 33.33% 23.08% 18.18%
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $95.66M $108.0M $153.2M
YoY Change -32.43% -29.5% -30.9%
LONG-TERM ASSETS
Property, Plant & Equipment $551.0K $588.0K $1.256M
YoY Change -23.68% -53.18% 484.19%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $57.00K $58.00K $87.00K
YoY Change -32.14% -33.33% 3.57%
Total Long-Term Assets $608.0K $880.0K $1.674M
YoY Change -46.53% -47.43% 72.22%
TOTAL ASSETS
Total Short-Term Assets $95.66M $108.0M $153.2M
Total Long-Term Assets $608.0K $880.0K $1.674M
Total Assets $96.26M $108.8M $154.8M
YoY Change -32.55% -29.7% -30.45%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $2.676M $4.447M $2.581M
YoY Change -26.48% 72.3% -39.93%
Accrued Expenses $3.090M $2.709M $4.976M
YoY Change -32.53% -45.56% 12.05%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $1.300M $2.100M $3.100M
YoY Change -58.06% -32.26% 10.71%
Total Short-Term Liabilities $7.034M $9.219M $10.61M
YoY Change -37.97% -13.14% -8.17%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $2.000M
YoY Change -100.0% -100.0% -59.18%
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $0.00 $0.00 $2.000M
YoY Change -100.0% -100.0% -59.18%
TOTAL LIABILITIES
Total Short-Term Liabilities $7.034M $9.219M $10.61M
Total Long-Term Liabilities $0.00 $0.00 $2.000M
Total Liabilities $7.034M $9.219M $12.59M
YoY Change -43.9% -26.76% -23.29%
SHAREHOLDERS EQUITY
Retained Earnings -$276.5M -$263.9M -$212.4M
YoY Change 21.74% 24.23% 55.5%
Common Stock $365.8M $363.6M $354.7M
YoY Change 2.35% 2.51% 3.45%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $89.23M $99.63M $142.2M
YoY Change
Total Liabilities & Shareholders Equity $96.26M $108.8M $154.8M
YoY Change -32.55% -29.7% -30.45%

Cashflow Statement

Concept 2017 Q3 2017 Q2 2016 Q2
OPERATING ACTIVITIES
Net Income -$12.59M -$13.35M -$15.03M
YoY Change -14.24% -11.19% -15.36%
Depreciation, Depletion And Amortization $50.00K $50.00K $50.00K
YoY Change 0.0% 0.0%
Cash From Operating Activities -$12.09M -$10.18M -$14.52M
YoY Change 9.61% -29.89% 0.97%
INVESTING ACTIVITIES
Capital Expenditures -$10.00K -$10.00K -$260.0K
YoY Change -96.15% 116.67%
Acquisitions
YoY Change
Other Investing Activities $300.0K $13.99M $4.080M
YoY Change -98.18% 242.89% -144.25%
Cash From Investing Activities $280.0K $13.99M $3.820M
YoY Change -98.3% 266.23% -140.9%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -730.0K -710.0K -720.0K
YoY Change 25.86% -1.39% -300.0%
NET CHANGE
Cash From Operating Activities -12.09M -10.18M -14.52M
Cash From Investing Activities 280.0K 13.99M 3.820M
Cash From Financing Activities -730.0K -710.0K -720.0K
Net Change In Cash -12.54M 3.100M -11.42M
YoY Change -359.63% -127.15% -51.11%
FREE CASH FLOW
Cash From Operating Activities -$12.09M -$10.18M -$14.52M
Capital Expenditures -$10.00K -$10.00K -$260.0K
Free Cash Flow -$12.08M -$10.17M -$14.26M
YoY Change 9.52% -28.68% 0.0%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2017Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
27483925 shares
CY2016Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
20026000
CY2017Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
2709000
CY2017Q2 us-gaap Assets Current
AssetsCurrent
107965000
CY2017Q2 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
102034000
CY2017Q2 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
293000
CY2017Q2 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
363547000
CY2017Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
4447000
CY2017Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-41000
CY2017Q2 us-gaap Assets
Assets
108845000
CY2017Q2 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
0
CY2017Q2 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
39000
CY2017Q2 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
74305000
CY2017Q2 us-gaap Available For Sale Securities Debt Securities Current
AvailableForSaleSecuritiesDebtSecuritiesCurrent
74266000
CY2017Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
31726000
CY2017Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2017Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
115000000 shares
CY2017Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
27449465 shares
CY2017Q2 us-gaap Cash And Cash Equivalents Fair Value Disclosure
CashAndCashEquivalentsFairValueDisclosure
27768000
CY2017Q2 us-gaap Cash Cash Equivalents And Short Term Investments
CashCashEquivalentsAndShortTermInvestments
106000000
CY2017Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2017Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
27449465 shares
CY2017Q2 us-gaap Common Stock Value
CommonStockValue
27000
CY2017Q2 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
1241000
CY2017Q2 us-gaap Liabilities
Liabilities
9219000
CY2017Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
108845000
CY2017Q2 us-gaap Liabilities Current
LiabilitiesCurrent
9219000
CY2017Q2 us-gaap Notes Payable Current
NotesPayableCurrent
2063000
CY2017Q2 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
102000
CY2017Q2 us-gaap Operating Leases Future Minimum Payments Due In Three Years
OperatingLeasesFutureMinimumPaymentsDueInThreeYears
82000
CY2017Q2 us-gaap Operating Leases Future Minimum Payments Due
OperatingLeasesFutureMinimumPaymentsDue
268000
CY2017Q2 us-gaap Operating Leases Future Minimum Payments Due In Two Years
OperatingLeasesFutureMinimumPaymentsDueInTwoYears
106000
CY2017Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
58000
CY2017Q2 us-gaap Operating Leases Future Minimum Payments Remainder Of Fiscal Year
OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear
80000
CY2017Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2017Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2017Q2 us-gaap Preferred Stock Value
PreferredStockValue
CY2017Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
1605000
CY2017Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2017Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2017Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
588000
CY2017Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-263907000
CY2017Q2 us-gaap Stockholders Equity
StockholdersEquity
99626000
CY2017Q2 zfgn Accrued Research And Development Expense Current
AccruedResearchAndDevelopmentExpenseCurrent
1073000
CY2017Q2 zfgn Tax Incentive Receivable Noncurrent
TaxIncentiveReceivableNoncurrent
234000
CY2017Q2 zfgn Tax Incentive Receivable Current
TaxIncentiveReceivableCurrent
368000
CY2015Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
35595000
CY2016Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
3733000
CY2016Q4 us-gaap Assets Current
AssetsCurrent
130899000
CY2016Q4 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
123430000
CY2016Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
347000
CY2016Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
359329000
CY2016Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
2572000
CY2016Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-80000
CY2016Q4 us-gaap Assets
Assets
131621000
CY2016Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
0
CY2016Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
80000
CY2016Q4 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
96922000
CY2016Q4 us-gaap Available For Sale Securities Debt Securities Current
AvailableForSaleSecuritiesDebtSecuritiesCurrent
96842000
CY2016Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
32352000
CY2016Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2016Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
115000000 shares
CY2016Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
27332551 shares
CY2016Q4 us-gaap Cash And Cash Equivalents Fair Value Disclosure
CashAndCashEquivalentsFairValueDisclosure
26588000
CY2016Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2016Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
27332551 shares
CY2016Q4 us-gaap Common Stock Value
CommonStockValue
27000
CY2016Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
2008000
CY2016Q4 us-gaap Liabilities
Liabilities
9894000
CY2016Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
131621000
CY2016Q4 us-gaap Liabilities Current
LiabilitiesCurrent
9894000
CY2016Q4 us-gaap Notes Payable Current
NotesPayableCurrent
3589000
CY2016Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
110000
CY2016Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
61000
CY2016Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2016Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2016Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2016Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
1358000
CY2016Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2016Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2016Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
661000
CY2016Q4 us-gaap Restructuring Reserve
RestructuringReserve
376000
CY2016Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-237549000
CY2016Q4 us-gaap Stockholders Equity
StockholdersEquity
121727000
CY2016Q4 zfgn Accrued Research And Development Expense Current
AccruedResearchAndDevelopmentExpenseCurrent
892000
CY2016Q4 zfgn Tax Incentive Receivable Current
TaxIncentiveReceivableCurrent
347000
CY2016Q4 zfgn Accrued Restructuring Costs Current
AccruedRestructuringCostsCurrent
376000
dei Amendment Flag
AmendmentFlag
false
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
4103000
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
4196931 shares
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-626000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-26319000
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
us-gaap Defined Contribution Plan Cost Recognized
DefinedContributionPlanCostRecognized
100000
us-gaap Defined Contribution Plan Employer Matching Contribution Percent
DefinedContributionPlanEmployerMatchingContributionPercent
0.02 pure
us-gaap Depreciation
Depreciation
89000
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.96
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2017
dei Document Type
DocumentType
10-Q
us-gaap Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
39000
dei Document Period End Date
DocumentPeriodEndDate
2017-06-30
dei Entity Registrant Name
EntityRegistrantName
Zafgen, Inc.
dei Entity Central Index Key
EntityCentralIndexKey
0001374690
dei Entity Incorporation Date Of Incorporation
EntityIncorporationDateOfIncorporation
2005-11-22
dei Entity Filer Category
EntityFilerCategory
Accelerated Filer
us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
95000
us-gaap Foreign Currency Transaction Gain Loss Unrealized
ForeignCurrencyTransactionGainLossUnrealized
21000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
6596000
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-998000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
1875000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
247000
us-gaap Interest Expense
InterestExpense
126000
us-gaap Investment Income Amortization Of Premium
InvestmentIncomeAmortizationOfPremium
145000
us-gaap Investment Income Net
InvestmentIncomeNet
474000
us-gaap Interest Paid
InterestPaid
103000
us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
22678000
us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-21860000
us-gaap Operating Expenses
OperatingExpenses
26801000
us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
-1444000
us-gaap Net Income Loss
NetIncomeLoss
-26358000
us-gaap Operating Income Loss
OperatingIncomeLoss
-26801000
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
443000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
20205000
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
39000
us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
200000
us-gaap Paid In Kind Interest
PaidInKindInterest
10000
us-gaap Payments For Restructuring
PaymentsForRestructuring
400000
us-gaap Payments To Acquire Available For Sale Securities Debt
PaymentsToAcquireAvailableForSaleSecuritiesDebt
57300000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
16000
us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
115000
us-gaap Proceeds From Sale And Maturity Of Available For Sale Securities
ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities
79994000
us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
1559000
us-gaap Restructuring And Related Cost Incurred Cost
RestructuringAndRelatedCostIncurredCost
24000
us-gaap Revenues
Revenues
0
us-gaap Share Based Compensation
ShareBasedCompensation
4103000
dei Trading Symbol
TradingSymbol
ZFGN
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
27379122 shares
us-gaap Use Of Estimates
UseOfEstimates
<div> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 6pt"> <b>Use of Estimates</b></p> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 6pt; TEXT-INDENT: 4%"> The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities as of the date of the condensed consolidated financial statements, and the reported amounts of expenses during the reporting periods. Significant estimates and assumptions reflected in these condensed consolidated financial statements include, but are not limited to, the accrual of research and development expenses and the valuation of stock-based awards. Estimates are periodically reviewed in light of changes in circumstances, facts and experience. Actual results could differ from the Company&#x2019;s estimates.</p> </div>
zfgn Increase Decrease In Tax Incentives Receivable
IncreaseDecreaseInTaxIncentivesReceivable
234000
zfgn Premium On Marketable Securities
PremiumOnMarketableSecurities
224000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
5610000
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
3986950 shares
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
204000
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-15569000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-32571000
us-gaap Defined Contribution Plan Cost Recognized
DefinedContributionPlanCostRecognized
100000
us-gaap Depreciation
Depreciation
102000
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-1.20
us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
21000
us-gaap Foreign Currency Transaction Gain Loss Unrealized
ForeignCurrencyTransactionGainLossUnrealized
108000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
10259000
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-1039000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-4710000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-374000
us-gaap Interest Expense
InterestExpense
300000
us-gaap Investment Income Amortization Of Premium
InvestmentIncomeAmortizationOfPremium
715000
us-gaap Investment Income Net
InvestmentIncomeNet
434000
us-gaap Interest Paid
InterestPaid
224000
us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
18093000
us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-32279000
us-gaap Operating Expenses
OperatingExpenses
32919000
us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
-1383000
us-gaap Net Income Loss
NetIncomeLoss
-32764000
us-gaap Operating Income Loss
OperatingIncomeLoss
-32919000
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
155000
us-gaap Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
193000
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
193000
us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
200000
us-gaap Paid In Kind Interest
PaidInKindInterest
24000
us-gaap Payments To Acquire Available For Sale Securities Debt
PaymentsToAcquireAvailableForSaleSecuritiesDebt
69907000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
660000
us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
55000
us-gaap Proceeds From Sale And Maturity Of Available For Sale Securities
ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities
88660000
us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
1438000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
22660000
us-gaap Revenues
Revenues
0
us-gaap Share Based Compensation
ShareBasedCompensation
5610000
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
27267830 shares
zfgn Increase Decrease In Tax Incentives Receivable
IncreaseDecreaseInTaxIncentivesReceivable
250000
zfgn Premium On Marketable Securities
PremiumOnMarketableSecurities
233000
CY2016Q4 us-gaap Restructuring And Related Cost Number Of Positions Eliminated Period Percent
RestructuringAndRelatedCostNumberOfPositionsEliminatedPeriodPercent
0.31 pure
CY2016 us-gaap Payments For Restructuring
PaymentsForRestructuring
847000
CY2016 us-gaap Restructuring And Related Cost Incurred Cost
RestructuringAndRelatedCostIncurredCost
1223000
zfgn Net Proceeds From Sale Of Securities
NetProceedsFromSaleOfSecurities
333300000
CY2016Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
2854000
CY2016Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-15043000
CY2016Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.55
CY2016Q2 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-51000
CY2016Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
4899000
CY2016Q2 us-gaap Interest Expense
InterestExpense
140000
CY2016Q2 us-gaap Investment Income Net
InvestmentIncomeNet
225000
CY2016Q2 us-gaap Operating Expenses
OperatingExpenses
15062000
CY2016Q2 us-gaap Net Income Loss
NetIncomeLoss
-15028000
CY2016Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-15062000
CY2016Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
34000
CY2016Q2 us-gaap Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
-15000
CY2016Q2 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-15000
CY2016Q2 us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
100000
CY2016Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
10163000
CY2016Q2 us-gaap Revenues
Revenues
0
CY2016Q2 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
27272225 shares
CY2017Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
2102000
CY2017Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-13325000
CY2017Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.49
CY2017Q2 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-5000
CY2017Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
3008000
CY2017Q2 us-gaap Interest Expense
InterestExpense
53000
CY2017Q2 us-gaap Investment Income Net
InvestmentIncomeNet
247000
CY2017Q2 us-gaap Operating Expenses
OperatingExpenses
13536000
CY2017Q2 us-gaap Net Income Loss
NetIncomeLoss
-13347000
CY2017Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-13536000
CY2017Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
189000
CY2017Q2 us-gaap Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
22000
CY2017Q2 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
22000
CY2017Q2 us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
100000
CY2017Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
10528000
CY2017Q2 us-gaap Revenues
Revenues
0
CY2017Q2 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
27407408 shares

Files In Submission

Name View Source Status
0001193125-17-252840-index-headers.html Edgar Link pending
0001193125-17-252840-index.html Edgar Link pending
0001193125-17-252840.txt Edgar Link pending
0001193125-17-252840-xbrl.zip Edgar Link pending
d408533d10q.htm Edgar Link pending
d408533dex311.htm Edgar Link pending
d408533dex312.htm Edgar Link pending
d408533dex321.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
zfgn-20170630.xml Edgar Link completed
zfgn-20170630.xsd Edgar Link pending
zfgn-20170630_cal.xml Edgar Link unprocessable
zfgn-20170630_def.xml Edgar Link unprocessable
zfgn-20170630_lab.xml Edgar Link unprocessable
zfgn-20170630_pre.xml Edgar Link unprocessable